Alone laser versus bevacizumab plus laser for diffuse diabetic macular edema (ALBA randomized trial)

PURPOSE: To report the 12-month results of laser (treatment G1) versus intravitreal bevacizumab combined with laser (treatment G2) in patients with diffuse diabetic macular edema (DME). METHODS: In this single-center randomized independent controlled trial, 32 patients were randomized to G1 (n = 15)...

Descripción completa

Detalles Bibliográficos
Autores principales: Pareja-Ríos, Alicia, de Armas-Ramos, Elena, Aldea-Perona, Ana, Bonaque-González, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812399/
https://www.ncbi.nlm.nih.gov/pubmed/33506177
http://dx.doi.org/10.1177/2515841420988210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812399/
https://www.ncbi.nlm.nih.gov/pubmed/33506177
http://dx.doi.org/10.1177/2515841420988210

Ejemplares similares